Compare iShares MSCI Germany (DAX) (EWG) vs Inovio Pharmaceuticals Inc (INO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Inovio Pharmaceuticals Inc — how do they compare? iShares MSCI Germany (DAX) trades at $43.83, while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: iShares MSCI Germany (DAX) is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| EWG | INO | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $44.56 | $2.87 |
52-Week Low | $38.08 | $0.66 |
Market Cap | — | $78.55M |
Enterprise Value | — | $49.56M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG trades at $43.87 with no recent price change. Technical indicators show a bullish trend from moving averages, though oscillators are neutral and RSI levels suggest overbought conditions. Recent news highlights European Central Bank policy decisions and German economic reforms influencing market sentiment.
The outlook is cautiously optimistic due to bullish technical signals, but limited fundamental data and overbought RSI levels pose risks. Investors should monitor European economic developments and company-specific financial updates for directional cues amid geopolitical and energy price volatility.
INO trades at $0.772, up 4.83% in the last 24 hours, but technical indicators signal a bearish trend. The company shows minimal revenue of $65,340 in 2025 with a net loss of $84.95 million, though it has beaten EPS estimates in recent quarters. Key developments include an upcoming Q2 2026 earnings report on August 12, 2026, and a pending FDA decision on INO-3107 by October 30, 2026.
The outlook hinges on FDA approval of INO-3107, with a consensus price target of $3.25 implying significant upside. However, high cash burn, negative margins, and legal scrutiny pose substantial risks. Investors should weigh the binary event against persistent financial challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →
